CoronaryAtlas logo
CoronaryAtlas
Caspase-3
Pathway / Myocardial injury (shared endpoint)

Caspase-3

CASP3protein

Caspase-3 activation drives cardiomyocyte apoptosis during myocardial ischemia and marks programmed cell death in infarction.

Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleApoptosis effector in cardiomyocyte injury; thrombus instability marker in activated platelets.
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000164305

Type I vs Type II discrimination

ScoresType-II-associated
R — rupture / Type-I
—
C — confounder / Type-II
62
A — assay feasibility
72
E — evidence strength
86
T1DI (composite)
16
Specificity differential (R−C)-46.9
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 2
2anemia / acute blood lossmag 2
3hypovolemia / dehydrationmag 1
4tachyarrhythmiamag 2
5hypoxemia / respiratory failuremag 2
6hypertensive emergencymag 2
7high-demand / peri-operative stressmag 2
Coverage: 7/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 21 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(4)